THIS IS QUEENSBOROUGH
queenschamber.org
TECHNOLOGY
LIFEWARE FOCUSES ON INTEGRATIVE MEDICINE
It’s no surprise that our healthcare system is complex, expensive and unwieldly to navigate. In 2020, healthcare costs were 18 percent of our $21 trillion GDP, with one third of that $3.8 trillion being spent on chronic conditions known to be mostly preventable. Moreover, many experts predict costs for our current approach to healthcare to rise unsustainably without producing widespread improvements in population wellness. Integrative Medicine (IM) is a precise, predictive and personalized approach to identifying and mitigating health risks. This wellness pathway focuses on “Health Span,” or how well your life serves you within a given “Life Span.” IM utilizes deep client relations, full-spectrum testing, genomic assessment, AI-assisted diagnostics, custom nutraceuticals, data-driven therapeutic scenarios, unique treatment systems, and ongoing support for anyone interested in optimizing their health span and maximizing their peak performance. As a New York start-up, LifeWare is a catalyst for IM, health span awareness and a shift in healthcare spending away from illness treatment and towards illness prevention. We are bringing IM closer to everyone’s lifestyle with smartly designed medical services pavilions that combine vitality and longevity concepts with whole body health goals, epigenetic risk mitigation and hormetic training practices in a health studio environment. Our planned secure network of Vigevity Pavilions can complement existing medical practices, be integrated into health clubs or aging communities, and become an efficient vehicle for helping new medical practitioners establish their own neighborhood IM footprint and receive assistive financing in the process. LifeWare is the innovation-forwellness brainchild of Ascher Shmulewitz, Debra Hubers, Benjamin Soffer, and Robert Colombo, a
18
globally respected team of research, medical, genomics, bioinformatics, intellectual property and bioengineering folks that have repeatedly pushed forward the leading-edge of medicine, life sciences, wellness, healthy-aging, bioengineering and scientific innovation for decades. Shmulewitz is a renowned and respected cardiologist, electrical engineer, bioengineer, educator, serial medical innovator and chief executive who has conceived, launched and developed over a dozen successful healthcare, diabetes prevention, diagnostic, nutrition, interventional, pharmaceutical, monitoring and medical device companies in the US, Israel and Europe. Hubers is sought-after expert in outcome-based medicine, epigenetics and women’s health who
founded and operates businesses devoted to genomic testing and assessment, customized bioidentical nutraceuticals and menopause revitalization chemistry that includes a compounding pharmacy providing personalized risk-reduction prescriptives to its clients. Soffer is an economist, lawyer, academic and entrepreneur who has built, developed and marketed organizations focused on stimulating healthcare and allied medical practices innovation and providing medical technology transfer pathways from academia to various commercial businesses, hospitals
and institutions in the US, Europe and Israel. Colombo is a systems engineer, bioengineer, educator and innovator who has founded successful companies to research and develop devices, models, sensors, algorithms, analytics, wearable technology, secure networks and systems for aging in place, trauma care, orthopedics, brain health, artificial organs, prosthetics, hemodialysis and transplant surgery. LifeWare has assembled a novel financing group that includes a publicly traded investment vehicle (infinitymedical.co.il) that de-risks and maintains convertible liquidity for interested investors. For more information, contact Robert Colombo at (908) 625-0388) or rsc@teknowsisinc.com.
EXPERT ADVICE
IS ASSET-BASED LENDING FOR YOU? During stressful economic times, as recent events have demonstrated, businesses have sought out asset-based lending to fuel their recovery as opposed to more traditional corporate loans. There is good reason; cash flow limitations due to reduced demand, supply chain issues, and global events have made standard borrowing structures unattainable for many organizations. Asset-based loans are secured by corporate working assets such as accounts receivable, inventory, and other fixed assets. These assets are analyzed and evaluated via field examinations and appraisals to establish appropriate advance rates on these assets, which provide a level of reduced risk for lenders.
The timeline involved to obtain an asset-based facility is similar to that of a traditional loan. However, when problematic issues or events arise, the turnaround time is generally quicker and easier for clients. The pandemic has made asset-based loans more popular than ever, as companies look for new ways to generate working capital and drive growth in an uncertain future. Here are a few of the advantages to asset-based loans to consider: • Improved Liquidity: The most important benefit that your company gets from using assetbased financing is improved liquidity. When used correctly, the facility can provide you with financial stability and predictable CONTINUED ON PAGE 23
Valley Bank can provide your company with the financial services and advice you need to ensure that your business recovers today and thrives tomorrow, and decide whether asset-based lending is right for your business. To learn more, contact Joseph M. Triscoli at (212) 253-4918 or JTriscoli@ valley.com.
